MedTrace Logo

Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

NCT00199628 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-01-15

No results posted yet for this study

Summary

Problems of compatibility between a mother and her child are frequent. The most well-known case can be illustrated by the fetomaternal blood group incompatibility (rhesus factor) which can induce severe anemia of the fetus.

The investigators recently proved that incompatibility between mother and child can concern an organ leading to a tissular alloimmunization. For example, neonatal membranous glomerulonephritis (a kidney disease) can result from this mechanism.

The purpose of this network is to detect and study neonatal diseases induced by tissular fetomaternal alloimmunization. The detection of these diseases will be performed by the mother's serum analysis.

Conditions

  • Glomerulonephritis, Membranous
  • Neonatal Diseases and Abnormalities
  • Hemochromatosis

Sponsors & Collaborators

  • University Hospital, Limoges

    lead OTHER

Principal Investigators

  • Vincent Guigonis, MD · Department of Pediatrics, Limoges University Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2013-08-31
Completion
2014-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00199628 on ClinicalTrials.gov